Ounas Health rais­es €1M pre-seed round to build a new prod­uct cat­e­go­ry in clin­i­cal insights

Ounas Health Oy has closed a pre-seed fund­ing round of approx­i­mate­ly €1 mil­lion. The round was led by Super­hero Cap­i­tal, with addi­tion­al par­tic­i­pa­tion from pub­lic fund­ing sources.

Ounas Health is devel­op­ing tech­nol­o­gy that trans­forms frag­ment­ed clin­i­cal data into action­able insights, help­ing make care more seam­less for both health­care pro­fes­sion­als and patients. The com­pa­ny is focused par­tic­u­lar­ly on the inter­sec­tion of health­care and eye care.

By com­bin­ing data, tech­nol­o­gy, and clin­i­cal under­stand­ing, Ounas Health aims to estab­lish a new cat­e­go­ry in dig­i­tal health cen­tered on com­pre­hen­sive and usable clin­i­cal insights.

“We are build­ing tech­nol­o­gy that turns frag­ment­ed health data into some­thing that can be mean­ing­ful­ly used in clin­i­cal work­flows. Our goal is to sup­port bet­ter deci­sion-mak­ing and improve the flow of care,” said Ville Wuoti­la, CEO & Co-Founder of Ounas Health.

“We were impressed by the strength of the found­ing team, their clear vision, and their abil­i­ty to exe­cute ear­ly on. Ounas Health is tack­ling a mean­ing­ful prob­lem with a focused approach, and we believe they are well posi­tioned to build some­thing sig­nif­i­cant in this space,” said Juha Ruo­ho­nen, Gen­er­al Part­ner at Super­hero Cap­i­tal.

With the new fund­ing, Ounas Health will focus on advanc­ing its core tech­nol­o­gy, val­i­dat­ing it in real clin­i­cal envi­ron­ments, and prepar­ing for inter­na­tion­al growth.

Source (text and image): OunasHealth